MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System

MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System

BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the MiniMed™ 780G system, marking a meaningful step forward in diabetes care…

MiniMed earns Health Canada nod for 780G with Simplera Sync

A product image of the 780G pump with Simplera Sync [Image courtesy of MiniMed]MiniMed (Nasdaq:MMED) announced today that it received approval in Canada for new software for its MiniMed 780G system. Health Canada authorization allows the company to deliver the MiniMed 780G automated insulin delivery system with both its Guardian 4 and Simplera Sync continuous glucose monitor (CGM) sensors. Additionally, the system now has compatibility with Fias…